AU3723695A - Transdermal device for delivery of levonorgestrel - Google Patents

Transdermal device for delivery of levonorgestrel

Info

Publication number
AU3723695A
AU3723695A AU37236/95A AU3723695A AU3723695A AU 3723695 A AU3723695 A AU 3723695A AU 37236/95 A AU37236/95 A AU 37236/95A AU 3723695 A AU3723695 A AU 3723695A AU 3723695 A AU3723695 A AU 3723695A
Authority
AU
Australia
Prior art keywords
levonorgestrel
delivery
transdermal device
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37236/95A
Inventor
Daniel C Duan
John R Hart
Jamieson C. Keister
Cheryl L. Moore
Steven M. Wick
David J Wirtanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Publication of AU3723695A publication Critical patent/AU3723695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU37236/95A 1994-09-14 1995-09-12 Transdermal device for delivery of levonorgestrel Abandoned AU3723695A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30615494A 1994-09-14 1994-09-14
US306154 1994-09-14
PCT/US1995/012158 WO1996008255A1 (en) 1994-09-14 1995-09-12 Transdermal device for delivery of levonorgestrel

Publications (1)

Publication Number Publication Date
AU3723695A true AU3723695A (en) 1996-03-29

Family

ID=23184070

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37236/95A Abandoned AU3723695A (en) 1994-09-14 1995-09-12 Transdermal device for delivery of levonorgestrel

Country Status (2)

Country Link
AU (1) AU3723695A (en)
WO (1) WO1996008255A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19526864A1 (en) * 1995-07-22 1997-01-23 Labtec Gmbh Hormone patches
DE19629468A1 (en) * 1996-07-11 1998-01-15 Schering Ag Transdermal therapeutic systems
DE19728516C2 (en) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS for administration of levonorgestrel and possibly estradiol
DE19739916C2 (en) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Use of a combination of a progestogen and an estrogen for the continuous inhibition of ovulation and possibly simultaneous treatment and / or prophylaxis of tumors of the mammary glands
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
AU644815B2 (en) * 1989-09-08 1993-12-23 Ortho-Mcneil Pharmaceutical, Inc. Solid matrix system for transdermal drug delivery
DE4229820C2 (en) * 1992-09-07 1998-12-03 Jenapharm Gmbh Progestogen-based pharmaceutical preparation

Also Published As

Publication number Publication date
WO1996008255A1 (en) 1996-03-21

Similar Documents

Publication Publication Date Title
HUP9901991A3 (en) Transdermal device for the delivery of flurbiprofen
AU3800497A (en) Device for dispensing small amounts of material
AU5588894A (en) An improved splint/therapeutic device
AU5106890A (en) Device for the transdermal delivery of nicotine
AU3493397A (en) Device for enhancing transdermal agent delivery or sampling
AU2923697A (en) Transdermal contraceptive delivery system
AU3718797A (en) Nonocclusive drug delivery device and process for its manufacture
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
HUP9802983A3 (en) Composition for transdermal delivery
AU7450196A (en) Device for delivering biological agents
AU1728797A (en) Comforter for delivering medicine
AU2109195A (en) Two-component device for the administration of drugs
PL343589A1 (en) Device for the transdermal delivery of diclofenac
HUP0001748A3 (en) Transdermal device for the delivery of testosterone
AU6410494A (en) Device for the transdermal administration of alprazolam
AU3825595A (en) Improved iontophoretic drug delivery device
AU4656596A (en) Transdermal formulation
AU7137196A (en) Contraceptive device
AU2345695A (en) Pharmaceutical composition for transdermal delivery
AU4774296A (en) Transdermal formulation
AU2559995A (en) Transdermal delivery of anti-epileptic drugs
AU4914396A (en) Transdermal formulation
AU3723695A (en) Transdermal device for delivery of levonorgestrel
AU3791997A (en) Device for delivery of dermatological ingredients
AU4636396A (en) Antiglucocorticoid medicament